Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
Download (PDF, 222KB)
December 3, 2019
/
Guidelines
,
News
Share
the Post
Related
Posts
Letter from Asian community and treatment advocates to Chief Executive Officer of CHAI regarding the Quick start program and concerns that patients would have to pay for sofosbuvir and diagnostics to be a part of the program in October 2016
Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
APN+ joins MTAAG in congratulating Malaysia on sofosbuvir compulsory license
Glecaprevir-Pibrentasvir Effective for Hepatitis C After Treatment Failure
Pricing of Indian generic sofosbuvir, 30th Jan,2016
Community group taking actions to enable greater access for generic HCV treatment
Updated WHO screening, care and treatment of persons with hepatitis C infection_ April 2016.
